SCHEMBL12468478

SCHEMBL12468478

CC(NCC([NH])=O)c1ccccc1O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.57
TSHR P16473 1/20 0.46
GABRA1 P14867 1/20 0.46
GABRB2 P47870 1/20 0.46
KMT2A Q03164 2/20 0.40
GAA P10253 1/20 0.40
MAPKAPK2 P49137 1/20 0.40
LMNA P02545 4/20 0.39
HPGD P15428 5/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HSD17B10 Q99714 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
APAF1 O14727 1/20 0.36
HTT P42858 1/20 0.36
CRHBP P24387 2/20 0.35
CRHR2 Q13324 2/20 0.35
ADRB2 P07550 1/20 0.35
ADRB1 P08588 1/20 0.35
MAPT P10636 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2989944 0.85 POLB (0.63) POLBTSHRGABRA1GABRB2KMT2A
SCHEMBL27381281 0.77 POLB (0.66) POLBTSHRGABRA1GABRB2KMT2A
SCHEMBL4135919 0.74 POLB (0.62) POLBTSHRGABRA1GABRB2KMT2A
SCHEMBL14022792 0.73 LMNA (0.47) POLBKMT2ALMNAHPGDSMN1; SMN2
SCHEMBL14022031 0.73 LMNA (0.47) POLBKMT2ALMNAHPGDSMN1; SMN2
SCHEMBL18095786 0.72 POLB (0.60) POLBTSHRGABRA1GABRB2KMT2A
SCHEMBL335140 0.72 POLB (0.60) POLBTSHRGABRA1GABRB2KMT2A
SCHEMBL8521832 0.72 GABRA1 (0.58) POLBTSHRGABRA1GABRB2KMT2A
SCHEMBL10243952 0.72 POLB (0.51) POLBTSHRGABRA1GABRB2MAPKAPK2
SCHEMBL5623571 0.72 POLB (0.54) POLBTSHRGABRA1GABRB2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2670765-A1 C-17 AND C-3 MODIFIED TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY Bristol-Myers Squibb Company (US) 2013-12-11 EP disclosed
WO-2012106190-A1 C-17 AND C-3 MODIFIED TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY BRISTOL-MYERS SQUIBB COMPANY (US) 2012-08-09 WO disclosed